CHARLES RIVER LABORATORIES (CRL) Stock Balance Sheet
USA - NYSE:CRL - US1598641074 - Common Stock
162.72 USD
+1.08 (+0.67%)
| MRQ (2025-9-27) | 2024 (2024-12-28) | 2023 (2023-12-30) | 2022 (2022-12-31) | 2021 (2021-12-25) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 207.10M | 194.61M | 276.77M | 233.91M | 241.21M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 65.00K | 62.00K | 68.00K | 998.00K | 1.06M | |||
| Receivables | 734.48M | 720.91M | 780.38M | 752.39M | 650.38M | |||
| Inventories | 302.55M | 278.54M | 380.26M | 255.81M | 199.15M | |||
| Other Current Assets | 287.91M | 208.94M | 171.19M | 195.92M | 182.29M | |||
| Total Current Assets | 1.53B | 1.40B | 1.61B | 1.44B | 1.27B | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.97B | 2.02B | 2.03B | 1.86B | 1.58B | |||
| Investments And Advances | 194.63M | 218.35M | 243.81M | 311.60M | 201.35M | |||
| Goodwill | 2.92B | 2.85B | 3.10B | 2.85B | 2.71B | |||
| Intangibles | 571.09M | 723.40M | 864.05M | 955.27M | 1.06B | |||
| Other Non-Current Assets | 327.80M | 320.41M | 349.66M | 189.54M | 191.76M | |||
| Total Non-Current Assets | 5.98B | 6.13B | 6.59B | 6.16B | 5.75B | |||
| TOTAL ASSETS | 7.51B | 7.53B | 8.20B | 7.60B | 7.02B | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 2.64M | 2.93M | 5.57M | 3.68M | 2.79M | |||
| Accrued Expenses | 498.59M | 465.59M | 496.02M | 463.36M | 508.18M | |||
| Accounts Payable | 169.62M | 140.34M | 168.94M | 205.91M | 198.13M | |||
| Other Current Liabilities | 451.05M | 385.25M | 384.55M | 418.63M | 324.08M | |||
| Total Current Liabilities | 1.12B | 994.10M | 1.06B | 1.09B | 1.03B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.19B | 2.24B | 2.65B | 2.71B | 2.66B | |||
| Deferred Taxes/Income | 123.01M | 106.96M | 191.35M | 215.58M | 239.72M | |||
| Other Non-Current Liabilities | 632.65M | 679.00M | 642.42M | 564.57M | 495.83M | |||
| Total Non-Current Liabilities | 2.99B | 3.07B | 3.54B | 3.53B | 3.46B | |||
| TOTAL LIABILITIES | 4.11B | 4.07B | 4.60B | 4.63B | 4.49B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 1.94B | 1.81B | 1.89B | 1.43B | 980.75M | |||
| Additional Paid In Capital | 2.02B | 1.97B | 1.91B | 1.80B | 1.72B | |||
| Minority Interest | 45.37M | 46.58M | 62.12M | 47.21M | 57.17M | |||
| Common Shares | 514.00K | 511.00K | 513.00K | 509.00K | 505.00K | |||
| Treasury Stock | -363.43M | 0 | 0 | 0 | 0 | |||
| Other Shareholders' Equity | -191.62M | -317.35M | -196.43M | -262.06M | -164.74M | |||
| Shares Outstanding | 49.22M | 51.14M | 51.34M | 50.94M | 50.48M | |||
| Tangible Book Value per Share | -1.7866 | -2.1217 | -7.0555 | -16.2705 | -24.5296 | |||
| Total Shareholders' Equity | 3.41B | 3.46B | 3.60B | 2.98B | 2.53B | |||
| TOTAL LIABILITIES AND EQUITY | 7.51B | 7.53B | 8.20B | 7.60B | 7.02B | |||
| Statistics | ||||||||
| Debt/Equity | 0.64 | 0.65 | 0.74 | 0.91 | 1.05 | |||
| Current Ratio | 1.37 | 1.41 | 1.52 | 1.32 | 1.23 | |||
| Return On Assets (ROA) | -1.11% | 0.14% | 5.79% | 6.40% | 5.57% | |||
| Return On Equity (ROE) | -2.45% | 0.30% | 13.20% | 16.34% | 15.42% | |||
| Return On Invested Capital (ROIC) | 5.84% | 6.66% | 7.30% | 8.00% | 8.35% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 6.03% | 6.86% | 7.59% | 8.30% | 8.70% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 13.86% | 15.71% | 17.94% | 21.09% | 25.31% | |||
All data in USD , ROIC based on taxRate of 0.21